Recovery and Outcomes From Stroke

Description

The investigators will perform follow-up on 500 cases of deep and lobar intracerebral hemorrhage to perform advanced neuroimaging before 45 days post stroke, and evaluations of motor and cognitive function at baseline, 3 months and 6 months to determine predictors of recovery, progressive cognitive or functional impairment.

Conditions

Intracerebral Hemorrhage

Study Overview

Study Details

Study overview

The investigators will perform follow-up on 500 cases of deep and lobar intracerebral hemorrhage to perform advanced neuroimaging before 45 days post stroke, and evaluations of motor and cognitive function at baseline, 3 months and 6 months to determine predictors of recovery, progressive cognitive or functional impairment.

Recovery and Outcomes From Stroke (ROSE) Sub-study of Genetic and Environmental Risk Factors for Hemorrhagic Stroke

Recovery and Outcomes From Stroke

Condition
Intracerebral Hemorrhage
Intervention / Treatment

-

Contacts and Locations

Chicago

University of Illinois Chicago, Chicago, Illinois, United States, 60612

Louisville

Baptist Health Louisville, Louisville, Kentucky, United States, 40207

Baltimore

University of Maryland, Baltimore, Maryland, United States, 21201

Boston

Massachusetts General Hospital, Boston, Massachusetts, United States, 02114

New York

Columbia University, New York, New York, United States, 10032

Durham

Duke University, Durham, North Carolina, United States, 27710

Cincinnati

University of Cincinnati, Cincinnati, Ohio, United States, 45267

Houston

Houston Methodist, Houston, Texas, United States, 77030

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age 18 years or greater, fulfillment of the criteria for Deep, Subcortical or Lobar Intracerebral Hemorrhage (ICH)
  • * No evidence of trauma, vascular malformation or aneurysm, or brain tumor as a cause of ICH.
  • * Ability of the patient or legal representative to provide informed consent
  • * Brainstem or Cerebellar ICH
  • * Patients Severely Affected by the ICH, Early Mortality, Hospice, or Withdraw of Care NOT eligible for ROSE

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Cincinnati,

Daniel Woo, MD, MS, PRINCIPAL_INVESTIGATOR, University of Cincinnati

Study Record Dates

2024-10